Aptamer-siRNA Chimera Targeting RORgammat in Th17 Cells for Topical Therapy of Psoriasis

Case ID:
1896
Web Published:
10/7/2015
Description:

Researchers at Oregon Health & Science University and at the Portland VA Medical Center have discovered and validated a novel aptamer-siRNA chimera targeting RORgammat in Th17 cells for topical treatment of psoriasis. If interested in learning more, please contact the Office of Technology Transfer and Business Development (techmgmt@ohsu.edu) and reference Tech Id No. 1896.

Patent Information:
Category(s):
Therapeutics
For Information, Contact:
Travis Cook
Senior Technology Development Manager
Oregon Health & Science University
cooktr@ohsu.edu
Inventors:
Cong-Qiu Chu
Gang Wang
Keywords:
Therapeutics - Dermatology
© 2018. All Rights Reserved. Powered by Inteum